Ovarian Brenner tumour: A morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium

Brenner, 1907, Das Oophoroma Folliculare, Frankfurt Z Pathol, 1, 150 Kuhn, 2012, Ovarian cancer is an imported disease: fact or fiction?, Curr Obstet Gynecol Rep, 1, 1, 10.1007/s13669-011-0004-1 Kurman, 2010, The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory, Am J Surg Pathol, 34, 433, 10.1097/PAS.0b013e3181cf3d79 Seidman, 2011, The fallopian tube-peritoneal junction: a potential site of carcinogenesis, Int J Gynecol Pathol, 30, 4, 10.1097/PGP.0b013e3181f29d2a Rabban, 2009, Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations, Am J Surg Pathol, 33, 111, 10.1097/PAS.0b013e31817d74a7 Seidman, 2008, Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors, Arch Pathol Lab Med, 132, 1753, 10.5858/132.11.1753 Kuhn, 2012, Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma, Int J Gynecol Pathol, 31, 416, 10.1097/PGP.0b013e31824cbeb4 Kuhn, 2012, TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions, J Pathol, 226, 421, 10.1002/path.3023 Kuhn, 2012, The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma, Am J Surg Pathol, 36, 1826, 10.1097/PAS.0b013e31825ec07a Tong, 2007, Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin?, Mod Pathol, 20, 856, 10.1038/modpathol.3800827 Li, 2011, Tubal origin of ‘ovarian’ low-grade serous carcinoma, Mod Pathol, 24, 1488, 10.1038/modpathol.2011.106 Barcena, 2011, WT1 expression in the female genital tract, Adv Anat Pathol, 18, 454, 10.1097/PAP.0b013e318234aaed Lin, 2006, Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5, Mol Cell Endocrinol, 248, 38, 10.1016/j.mce.2005.11.035 Hanukoglu, 1992, Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis, J Steroid Biochem Mol Biol, 43, 779, 10.1016/0960-0760(92)90307-5 Tang, 1990, Ultrastructure of malignant Brenner tumor of the ovary, Chin Med J (Engl), 103, 759 Auersperg, 2013, Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis?, Gynecol Oncol, 130, 246, 10.1016/j.ygyno.2013.03.021 Slack, 2007, Metaplasia and transdifferentiation: from pure biology to the clinic, Nat Rev Mol Cell Biol, 8, 369, 10.1038/nrm2146 Hagiwara, 2004, Cell biology of normal and abnormal ciliogenesis in the ciliated epithelium, Int Rev Cytol, 234, 101, 10.1016/S0074-7696(04)34003-9 Lei, 2003, Epididymal phenotype in luteinizing hormone receptor knockout animals and its response to testosterone replacement therapy, Biol Reprod, 68, 888, 10.1095/biolreprod.102.009738 Scully, 1964, Oxidative-enzyme activity in normal and pathologic human ovaries, Obstet Gynecol, 24, 667 Song, 2011, Ovarian enzymatically active stromal cells can be a promoter of ovarian surface epithelial tumor, Med Hypotheses, 77, 356, 10.1016/j.mehy.2011.05.014 Penning, 2009, Steroid hormone transforming aldo–keto reductases and cancer, Ann N Y Acad Sci, 1155, 33, 10.1111/j.1749-6632.2009.03700.x Papadatos-Pastos, 2011, Revisiting the role of antiandrogen strategies in ovarian cancer, Oncologist, 16, 1413, 10.1634/theoncologist.2011-0164